The share of hospital use in oxycodone-alone products and the combination product ranged between 25–28% and 32–40%, respectively, both figures showing a decreasing trend over the years.
← all excerpts
Post-mortem oxycodone blood concentrations of hospitalized cancer and surgery patients compared with fatal poisonings.
1
—
—